4.5 Article

A glycoengineered antigen exploiting a conserved protein O-glycosylation pathway in the Burkholderia genus for detection of glanders infections

期刊

VIRULENCE
卷 12, 期 1, 页码 493-506

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/21505594.2021.1876440

关键词

Burkholderia mallei; protein glycosylation; category B agents; complement fixation; peanut agglutinin; horse infections

资金

  1. Medical Research Council (Confidence in Concept grant) [CD1617-CIC04]
  2. National Health and Medical Research Council of Australia (NHMRC) [APP1100164]
  3. National Health and Medical Research Council (Australia) [APP1100164]
  4. Medical Research Council Canada (UK) [CD1617-CIC04]

向作者/读者索取更多资源

This study utilized the protein O-glycosylation pathway in Burkholderia to develop a diagnostic tool for glanders. The newly developed diagnostic method showed high specificity and sensitivity in detecting glanders-infected horses, providing crucial support for the control and elimination of Burkholderia infections. The results indicate that protein O-glycosylation in Burkholderia can serve as a biomarker for the diagnosis of Burkholderia-associated infections.
We recently described a protein O-glycosylation pathway conserved in all species of the Burkholderia genus that results in the synthesis and incorporation of a trisaccharide glycan to membrane-exported proteins. Here, we exploited this system to construct and evaluate a diagnostic tool for glanders. Burkholderia mallei, the causative agent of glanders, is a highly infectious and fatal zoonotic pathogen that infects horses, mules, donkeys, and occasionally humans. A highly sensitive and specific diagnostic tool is crucial for the control, elimination, and eradication of B. mallei infections. We constructed plasmids carrying synthetic genes encoding a modified, previously unannotated Burkholderia glycoprotein containing three glycosylation sequons fused to the cholera toxin B-subunit. The resulting proteins were glycosylated in the B. cenocepacia K56-2 parental strain, but not in glycosylation-deficient mutants, as determined by SDS-PAGE and fluorescent lectin blots. One of these glycoproteins was used as an antigen in ELISA and western blots to screen a panel of serum samples collected from glanders-infected and healthy horses, which were previously investigated by complement fixation test and indirect ELISA based on a semi-purified fraction of B. mallei. We show that ELISA and western blot assays based on our glycoprotein antigen provide 100% specificity, with a sensitivity greater than 88%. The glycoprotein antigen was recognized by serum samples collected from patients infected with B. pseudomallei, B. mallei, B. multivorans, and B. cenocepacia. Our results indicate that protein O-glycosylation in Burkholderia can be exploited as a biomarker for diagnosis of Burkholderia-associated infections.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据